coronavirus
cov
infect
varieti
mammalian
avian
speci
caus
seriou
diseas
human
cat
mice
bird
form
sever
acut
respiratori
syndrom
sar
felin
infecti
periton
fip
mous
hepat
avian
infecti
bronchiti
respect
outbreak
sar
demonstr
human
vulner
cov
epidem
cov
member
coronavirida
famili
contain
larg
positivesens
singlestrand
rna
genom
approxim
kb
length
express
sever
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
protein
addit
structur
protein
mani
nonstructur
protein
nsp
also
express
coronavirida
twothird
genom
found
within
region
contain
openread
frame
openread
frame
encod
rnadepend
rna
polymeras
rdrp
helicas
nsp
protein
initi
synthes
two
larg
polyprotein
synthesi
involv
program
ribosom
frame
shift
translat
protein
cleav
virusencod
proteinas
encod
protein
encod
protein
remain
third
genom
gene
structur
protein
encod
fix
order
semn
variabl
number
orf
encod
accessori
protein
present
gene
cyclosporin
csa
wellknown
immunosuppress
drug
bind
cellular
cyclophilin
cyp
inhibit
calcineurin
calciumcalmodulinactiv
serinethreoninespecif
phosphatas
inhibit
calcineurin
block
transloc
nuclear
factor
activ
cell
nfat
cytosol
nucleu
thu
prevent
transcript
gene
encod
cytokin
seven
major
cyp
humanscyclophilin
cypa
cyclophilin
b
cypb
cyclophilin
c
cypc
cyclophilin
cypd
cyclophilin
e
cype
cyclophilin
cyclophilin
nk
cypnk
gener
link
genom
cyp
isomeras
ppias
physiolog
function
describ
mani
year
includ
chaperon
foldas
activ
cyp
thought
involv
divers
signal
pathway
includ
mitochondri
apoptosi
rna
splice
adapt
immun
howev
protein
act
substrat
cyp
pathway
yet
identifi
recent
sever
research
shown
cypa
involv
pathogenesi
viral
infect
cardiovascular
diseas
cancer
cypa
play
critic
role
replic
virus
human
immunodefici
viru
type
hepat
c
viru
hcv
vesicular
stomat
viru
vsv
human
papilloma
viru
vaccinia
viru
therefor
csa
nonimmunosuppress
compound
bind
cyp
inhibit
hcv
replic
also
sever
laboratori
report
csa
suppress
replic
variou
kind
cov
review
focus
relationship
csa
replic
cov
introduc
recent
advanc
area
cov
replic
reli
varieti
host
factor
also
constitut
potenti
interest
target
antivir
therapi
felin
cov
fcov
classifi
two
biotyp
ubiquit
felin
enter
cov
fecv
infecti
periton
viru
fipv
wide
accept
theori
vitro
studi
fipv
aris
mutat
parent
fecv
gastrointestin
tract
infect
cat
mani
strategi
cure
fip
attempt
interferon
inhibit
fipv
vitro
ineffect
vivo
variou
immunosuppress
glucocorticoid
cyclophosphamid
also
investig
howev
although
agent
prolong
life
outcom
fipv
infect
remain
fatal
thu
effect
vaccin
therapeut
medicin
fipv
still
need
discov
replic
fcov
inhibit
csa
dosedepend
manner
csa
bind
cellular
cyp
block
nfat
pathway
therefor
tri
use
immunosuppress
agent
bind
bind
protein
fkbp
block
nfat
pathway
howev
effect
fcov
replic
translat
result
indic
inhibit
effect
csa
fcov
involv
nfat
pathway
relat
immunosuppress
effect
examin
whether
suppress
effect
csa
fipv
replic
depend
pglycoprotein
pathway
incub
fipvinfect
cell
cyclosporin
h
csh
pglycoprotein
pathwayspecif
inhibitor
howev
inhibit
occur
determin
whether
effect
csa
involv
activ
interferonstimul
gene
respons
cell
interferonstimul
respons
element
isr
luciferas
report
assay
perform
howev
neither
interferon
stimul
treatment
csa
effect
isrepromot
activ
cell
therefor
role
cyp
appear
requir
viral
replic
de
wild
et
al
report
csa
inhibit
replic
cov
human
cov
mous
hepat
viru
mhv
use
green
fluoresc
protein
gfp
express
recombin
cov
name
use
cell
cell
cell
stabli
express
receptor
infect
investig
whether
csa
inhibit
replic
cov
cell
infect
cell
infect
treat
csa
gfp
express
decreas
infect
cell
although
lesser
degre
cell
remark
approxim
infect
cell
remain
posit
immunofluoresc
analysi
even
csa
concentr
result
suggest
replic
inde
impair
although
fulli
block
use
viru
may
one
natur
csaresist
virus
sometim
present
viru
pool
sever
rna
virus
requir
cypa
cypb
replic
process
describ
hcv
equin
arteriviru
eav
japanes
enceph
viru
vsv
west
nile
viru
wnv
therefor
de
wild
et
al
also
examin
whether
csa
might
exert
inhibitori
effect
cov
replic
inhibit
cyp
function
indirect
inhibit
virusspecif
function
howev
found
activ
rdrp
directli
affect
addit
deplet
cellular
cypa
cypb
knockdown
experi
significantli
affect
replic
howev
possibl
remain
cyp
small
interfer
rna
sirna
treat
cell
suffici
support
normal
viru
replic
vivo
virul
factor
whose
action
link
earli
stage
immun
respons
includ
antagonist
activ
interferon
signal
inhibit
host
protein
synthesi
pfefferl
et
al
perform
genomewid
yeast
twohybrid
interact
screen
amino
n
termin
region
protein
identifi
protein
act
interact
partner
cypa
cypb
cyph
cypg
molecul
known
function
regul
nfat
pathway
play
import
role
immun
system
overexpress
infect
strongli
increas
signal
nfat
pathway
enhanc
induct
presenc
phorbol
pma
ionomycin
result
suggest
nfat
signal
pathway
influenc
fundament
trigger
immun
cell
activ
provid
explan
cytokin
dysregul
immunedepend
pathogenesi
observ
sever
case
sar
addit
pfefferl
et
al
found
csa
inhibit
replic
cov
member
includ
human
fcov
serotyp
ii
porcin
transmiss
gastroenter
viru
tgev
avian
infecti
bronchiti
viru
ibv
evid
show
csa
bind
intracellular
cyp
block
nfat
pathway
howev
appear
inhibit
effect
csa
viru
replic
independ
nfat
pathway
although
interact
pfefferl
et
al
examin
whether
inhibit
replic
cov
addit
report
affect
replic
fcov
moreov
brockway
denison
show
delet
residu
aminotermin
half
block
product
infect
viru
sinc
recombin
virus
delet
ntermin
half
appear
bind
cyp
difficult
elucid
exact
role
interact
complex
may
inhibit
function
cyp
requir
viru
replic
use
gfpexpress
recombin
equin
arter
viru
eav
porcin
reproduct
respiratori
syndrom
viru
prrsv
de
wild
et
al
recent
report
csa
inhibit
arterivirus
distantli
relat
cov
togeth
coronavirida
ronivirida
famili
constitut
order
nidoviral
csa
immunosuppress
agent
nonimmunosuppress
agent
inhibit
eav
prrsv
replic
csa
strongli
reduc
eav
progeni
titer
almost
reduct
csa
data
correl
well
bare
detect
express
level
n
protein
treatment
csa
moreov
treatment
also
result
approxim
reduct
infecti
progeni
csa
reduct
achiev
treatment
compound
compar
effect
eav
significantli
higher
concentr
csa
requir
complet
block
infecti
progeni
prrsv
csa
requir
achiev
reduct
even
treatment
result
approxim
reduct
approxim
reduct
possess
higher
affin
cyp
csa
seen
result
eav
experi
howev
concentr
requir
inhibit
viru
replic
differ
viru
requir
concentr
may
also
affect
use
differ
cell
line
replic
experi
de
wild
et
al
also
report
eav
replic
inhibit
knockdown
cypa
express
knockdown
cypb
express
titer
viru
progeni
decreas
approxim
fourfold
cypaknockdown
cell
compar
nontarget
cell
experi
perform
use
transient
express
sirna
cyp
although
approxim
reduct
cyp
express
level
achiev
residu
cyp
express
approxim
remain
knockdown
may
suffici
normal
viru
replic
howev
compar
inhibit
effect
csa
gfpexpress
recombin
viru
inhibit
effect
cypa
knockdown
much
lower
consequ
mechan
effect
cypa
viru
replic
direct
indirect
interact
cellular
factor
signal
pathway
exclud
csa
inhibit
replic
variou
kind
rna
virus
includ
hcv
sever
flavivirus
publish
report
hcv
replic
viru
hcv
replic
affect
multipl
cyp
ppias
activ
cyp
play
role
assembl
hcv
viral
replicas
complex
vrc
particular
cytosol
cypa
shown
critic
hcv
vrc
assembl
like
affect
hcv
polyprotein
process
fusion
protein
cleavag
rdrp
addit
cypaindepend
mutant
show
cypa
like
involv
fold
nonstructur
region
may
requir
structur
shift
toward
extend
conform
hcv
replic
howev
direct
physic
interact
rdrp
cov
cyp
report
emmprin
type
transmembran
protein
identifi
main
signal
receptor
extracellular
cypa
although
none
protein
directli
bound
n
protein
bound
cypa
interact
surfac
plasmon
reson
analysi
antagonist
show
high
rate
bind
cell
inhibitori
effect
result
demonstr
play
function
role
facilit
invas
host
cell
csa
inhibit
cypa
function
may
suppress
product
progeni
cyp
may
affect
conform
viral
rdrp
rna
templat
turn
could
alter
templat
activ
rdrp
n
protein
vsv
interact
cypa
cypa
incorpor
viru
particl
appear
act
chaperon
n
protein
wrap
genom
rna
produc
function
templat
transcript
also
cypb
resid
protein
endoplasm
reticulum
er
golgi
found
regul
rnabind
abil
hcv
rdrp
ergolgi
resid
protein
cypc
also
affect
traffick
viral
protein
n
protein
coronavirida
famili
virus
bind
cyp
possibl
cyp
act
chaperon
n
protein
play
import
role
replic
interact
play
critic
role
infect
complex
could
induc
phosphoryl
matrix
protein
regul
detach
revers
transcriptas
complex
membran
promot
transit
step
hemifus
moreov
propos
interact
might
indirectli
affect
capsid
conform
effici
incorpor
cypa
virion
mediat
direct
prolyl
peptid
bond
cypa
prolinerich
loop
capsid
protein
disrupt
cypa
incorpor
gag
mutat
treatment
csa
attenu
infect
progeni
virus
howev
evid
complex
affect
step
fusion
cov
csa
inhibit
nidoviral
replic
vitro
although
deplet
cellular
cypa
knockdown
experi
inhibit
viru
replic
eav
affect
tabl
also
show
role
cyp
cov
replic
figur
littl
known
exact
role
cypa
cov
replic
csa
inhibit
viru
replic
bind
cyp
proteom
approach
structur
studi
provid
detail
inform
role
cyp
regul
composit
structur
viral
protein
complex
cyclosporin
csa
analog
target
cellular
cyp
describ
thu
virus
resist
cyclosporin
unlik
develop
antivir
compound
target
cellular
factor
gener
produc
less
drug
resist
target
viral
protein
therefor
cyclosporin
good
candid
therapeut
medicin
cov
rna
viru
infect
